We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SAVA market cap is 951.39M. The company's latest EPS is USD -2.2491 and P/E is -0.19.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.35M | -20.94M | -26.51M | -29.14M | -27.88M |
| Net Income | -20.26M | -19.13M | -24.27M | -26.38M | -25.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.96M | -6.79M | -32.87M | -80.02M | -105.96M |
| Net Income | -4.63M | -6.33M | -32.39M | -76.25M | -97.22M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 207.29M | 234.83M | 218.11M | 197.25M | 172.53M |
| Total Liabilities | 8.57M | 7.3M | 14.11M | 17.9M | 17.41M |
| Total Equity | 198.72M | 227.54M | 204.01M | 179.35M | 155.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.49M | 94.3M | 266.78M | 234.83M | 151.66M |
| Total Liabilities | 1.39M | 2.1M | 12.87M | 7.3M | 14.2M |
| Total Equity | 22.1M | 92.2M | 253.92M | 227.54M | 137.47M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -56.19M | -77.51M | -13.26M | -33.18M | -59.71M |
| Investing | -3.05M | -2.71M | -357k | -351k | -373k |
| Financing | 466k | 47.8M | 64k | 953k | 1.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.51M | -5.38M | -30.2M | -77.51M | -82.03M |
| Investing | -18k | 360k | -22.21M | -2.71M | -414k |
| Financing | 5.81M | 75.45M | 192.34M | 47.8M | 2.56M |
| Market Cap | 951.39M |
| Price to Earnings Ratio | -0.19 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.15 |
| Price to Book Ratio | 0.13 |
| Dividend Yield | - |
| Shares Outstanding | 43.23M |
| Average Volume (1 week) | 792.86k |
| Average Volume (1 Month) | 1.03M |
| 52 Week Change | 0.23% |
| 52 Week High | 32.10 |
| 52 Week Low | 12.3202 |
| Spread (Intraday) | 0.55 (2.45%) |
| Company Name | Cassava Sciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cassavasciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
